New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:31 EDTARGSArgos data shows disease eradication potential, says JMP Securities
JMP Securities believes that immunological data from patients on Argos' AGS-004 indicates that the drug can affect latent reservoirs of HIV virus. The firm views this as a key step in virus eradication, and it thinks the data suggest the drug can be effectively combined with PD-1/PDL-1 inhibitors in HIV and oncology. It reiterates an Outperform rating on the stock.
News For ARGS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
16:21 EDTARGSArgos Therapeutics reports Q3 EPS (77c), consensus (55c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use